CoChat

miR-297 modulates multidrug resistance in human colorectal carcinoma by down-regulating MRP-2

The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.

Abstract

Colorectal carcinoma is a frequent cause of cancer-related death in men and women. miRNAs (microRNAs) are endogenous small non-coding RNAs that regulate gene expression negatively at the post-transcriptional level. In the present study we investigated the possible role of microRNAs in the development of MDR (multidrug resistance) in colorectal carcinoma cells. We analysed miRNA expression levels between MDR colorectal carcinoma cell line HCT116/L-OHP cells and their parent cell line HCT116 using a miRNA microarray. miR-297 showed lower expression in HCT116/L-OHP cells compared with its parental cells. MRP-2 (MDR-associated protein 2) is an important MDR protein in platinum-drug-resistance cells and is a predicted target of miR-297. Additionally miR-297 was down-regulated in a panel of human colorectal carcinoma tissues and negatively correlated with expression levels of MRP-2. Furthermore, we found that ectopic expression of miR-297 in MDR colorectal carcinoma cells reduced MRP-2 protein level and sensitized these cells to anti-cancer drugs in vitro and in vivo. Taken together, our findings suggest that miR-297 could play a role in the development of MDR in colorectal carcinoma cells, at least in part by modulation of MRP-2.

Overview

Integrity signals

Registry

Crossref · 10.1042/bj20120386

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 50 references

Research works printed but not linked: 2

  1. Tokunaga, 2001, Effects of after surgery, Oncol. Rep., 8, 815
  2. Pan, 2009, MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells, Mol. Pharmacol., 75, 1374, 10.1124/mol.108.054163 · DOI · Paper page

Cited by

Metadata

Authors
Xu, K., Liang, X., Shen, K., Cui, D., Zheng, Y., Xu, J., Fan, Z., Qiu, Y., Li, Q., Ni, L., & Liu, J.
Affiliations
  • East China University of Science and Technology (CN)
  • Shanghai University of Traditional Chinese Medicine (CN)
  • Shanghai Jiao Tong University (CN)
Corresponding author
  • Xu, Ke
  • Liang, Xin
  • Shen, Ke
  • Cui, Daling
  • Zheng, Yuanhong
  • Liu, Jianwen
Venue
Biochemical Journal
Published
2012-08-14
Volume
446
Issue
2
Pages
291-300
ISSN
  • 0264-6021 (ISSN-L)
  • 1470-8728
OpenAlex
W2001233915
Cited by
93
References
51
Citations by year
2025: 4 · 2024: 4 · 2023: 2 · 2022: 6 · 2021: 9 · 2020: 7 · 2019: 7 · 2018: 6 · 2017: 7 · 2016: 15 · 2015: 7 · 2014: 10 · 2013: 7 · 2012: 2
FWCI
4.12
Type
journal article
Language
en
Open access
closed
Locations
  • Biochemical Journal (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
Keywords
microRNA, multidrug resistance, colorectal cancer, MRP2, TAP1, platinum resistance, chemosensitization, miRNA expression profiling, efflux pumps
MeSH terms
Multidrug Resistance-Associated Protein 2, Adenocarcinoma, Aged, Antineoplastic Agents, Female, Humans, Male, Middle Aged, Neoplasm Proteins, RNA, Messenger, RNA, Neoplasm, Colorectal Neoplasms, Genetic Therapy, Down-Regulation, Drug Resistance, Multiple, Drug Resistance, Neoplasm, Gene Silencing, ATP-Binding Cassette, Sub-Family C Proteins, Multidrug Resistance-Associated Proteins, RNA, Small Interfering, MicroRNAs, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.